Compounds > 3-hydroxyflavone
Page last updated: 2024-08-21

3-hydroxyflavone and Carcinoma, Lewis Lung

3-hydroxyflavone has been researched along with Carcinoma, Lewis Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, KS; Bae, HS; Kim, CH; Kim, SH; Ko, SG; Lee, EO; Lee, HJ; Lu, J1
Chabot, GG; Scherman, D; Seguin, J; Touil, YS1
Auzeil, N; Boulinguez, F; Chabot, GG; Regazzetti, A; Saighi, H; Scherman, D; Touil, YS1
Arnaud, P; Brossard, D; Chabot, GG; Crauste-Manciet, S; Ragelle, H; Scherman, D; Seguin, J1
Bessodes, M; Boyer, R; Brullé, L; Chabot, GG; Lu, YM; Mignet, N; Ramos Romano, M; Scherman, D; Seguin, J; Touil, YS1

Other Studies

5 other study(ies) available for 3-hydroxyflavone and Carcinoma, Lewis Lung

ArticleYear
Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis.
    Cancer letters, 2008, Nov-08, Volume: 270, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Lewis Lung; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Female; Flavonols; Injections, Intraperitoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Quercetin; Time Factors

2008
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cyclophosphamide; Endothelial Cells; Female; Flavonoids; Flavonols; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NIH 3T3 Cells; Tubulin Modulators; Tumor Burden

2011
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
    Biochemical pharmacology, 2011, Dec-01, Volume: 82, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Collagen; Drug Combinations; Endothelial Cells; Female; Flavones; Flavonoids; Flavonols; Glucuronides; Laminin; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Proteoglycans

2011
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
    International journal of pharmaceutics, 2012, May-10, Volume: 427, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Carcinoma, Lewis Lung; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Emulsions; Endothelial Cells; Excipients; Female; Flavonoids; Flavonols; Half-Life; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Solubility; Solvents; Surface-Active Agents

2012
Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
    International journal of pharmaceutics, 2013, Feb-28, Volume: 444, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Lewis Lung; Cell Line, Tumor; Cyclophosphamide; Female; Flavonoids; Flavonols; Liposomes; Mice; Mice, Inbred C57BL; Tumor Burden

2013